Unveiling the Global Surge of Mpox (Monkeypox): A comprehensive review of current evidence
The Microbe,
Journal Year:
2024,
Volume and Issue:
4, P. 100141 - 100141
Published: Aug. 17, 2024
Monkeypox,
now
named
mpox,
has
emerged
as
a
significant
public
threat,
evidenced
by
the
2022
outbreak
affecting
over
seventy
countries
globally.
This
infectious
disease
presents
debilitating
symptoms,
including
painful
skin
rashes,
mucosal
lesions,
enlarged
lymph
nodes,
and
fever.
The
situation
intensifies
with
concerns
about
novel
transmission
route,
specifically
through
sexual
contact,
evolution
of
more
transmissible
strains.
Complicating
matters
further
is
documented
spillback
mpox
from
humans
to
animals,
raising
potential
for
new
animal
reservoirs.
study
utilized
systematic
approach
gather,
analyse,
interpret
data
regarding
global
outbreaks,
phylogenomics,
human
APOBEC3
enzyme
activity,
antiviral
resistance
issues,
application
One
Health
intervention.
Emphasizing
covers
various
aspects,
zoonotic
origins,
pathogenesis,
changing
epidemiological
landscapes,
phylogenomic
diversity,
clade
dynamics.
review
underscores
crucial
role
collaboration
in
understanding
combatting
making
it
valuable
resource
shaping
effective
prevention
control
measures
on
scale.
Language: Английский
Inferring active mutational processes in cancer using single cell sequencing and evolutionary constraints
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 27, 2025
Ongoing
mutagenesis
in
cancer
drives
genetic
diversity
throughout
the
natural
history
of
cancers.
As
activities
mutational
processes
are
dynamic
evolution,
distinguishing
signatures
'active'
and
'historical'
has
important
implications
for
studying
how
tumors
evolve.
This
can
aid
understanding
mutagenic
states
at
time
presentation,
associating
active
process
with
therapeutic
resistance.
bulk
sequencing
primarily
captures
historical
processes,
we
studied
whether
ultra-low-coverage
single-cell
whole-genome
(scWGS),
which
measures
distribution
mutations
across
hundreds
or
thousands
individual
cells,
could
enable
distinction
between
processes.
While
technical
challenges
data
sparsity
have
limited
mutation
analysis
scWGS,
show
that
these
contain
valuable
information
about
To
robustly
interpret
single
nucleotide
variants
(SNVs)
introduce
ArtiCull,
a
method
to
identify
remove
SNV
artifacts
by
leveraging
evolutionary
constraints,
enabling
reliable
detection
signature
analysis.
Applying
this
approach
scWGS
from
pancreatic
ductal
adenocarcinoma
(PDAC),
triple-negative
breast
(TNBC),
high-grade
serous
ovarian
(HGSOC),
uncover
temporal
spatial
patterns
In
PDAC,
observe
increase
mismatch
repair
deficiency
(MMRd).
cisplatin-treated
TNBC
patient-derived
xenografts,
therapy-induced
inactivation
APOBEC3
activity.
HGSOC,
distinct
mutagenesis,
including
late
tumor-wide
activation
one
case
clade-specific
enrichment
another.
Additionally,
detect
clone-specific
SBS17
activity,
clone
previously
linked
recurrence.
Our
findings
establish
as
powerful
may
influence
ongoing
clonal
evolution
Language: Английский
APOBEC3 Proteins: From Antiviral Immunity to Oncogenic Drivers in HPV-Positive Cancers
Viruses,
Journal Year:
2025,
Volume and Issue:
17(3), P. 436 - 436
Published: March 18, 2025
The
human
APOBEC
superfamily
consists
of
eleven
cytidine
deaminase
enzymes.
Among
them,
APOBEC3
enzymes
play
a
dual
role
in
antiviral
immunity
and
cancer
development.
enzymes,
including
APOBEC3A
(A3A)
APOBEC3B
(A3B),
induce
mutations
viral
DNA,
effectively
inhibiting
replication
but
also
promoting
somatic
the
host
genome,
contributing
to
A3A
A3B
are
linked
mutational
signatures
over
50%
cancers,
with
being
potent
mutagen.
A3B,
one
first
carcinogenesis,
plays
significant
HPV-associated
cancers
by
driving
mutagenesis
tumor
progression.
A3A_B
deletion
polymorphism
results
hybrid
gene,
leading
increased
expression
enhanced
mutagenic
potential.
Such
has
been
an
elevated
risk
certain
particularly
populations
where
it
is
more
prevalent.
This
review
explores
molecular
mechanisms
proteins,
highlighting
their
roles
defense
tumorigenesis.
We
discuss
clinical
implications
genetic
variants,
such
as
polymorphism,
mainly
HPV
infection
associated
providing
comprehensive
understanding
contributions
both
restriction
Language: Английский
Mutational landscapes of brain metastases across various histological subtypes of lung cancer
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 21, 2025
Abstract
The
knowledge
of
the
genetic
landscape
lung
cancer
brain
metastases
(BM)
is
scarce
due
to
low
availability
intracranial
samples.
Here,
we
investigated
features
142
BM
by
next-generation
sequencing
in
various
histological
subtypes
(19
small-cell
(SCLC),
123
from
non-small-cell
(NSCLC)
including
79
adenocarcinomas
(LUAD),
31
squamous
carcinomas
(LUSC),
and
13
large-cell
(LCLC).
TP53,
H3F3A,
PMS2
genes
were
mutated
over
20%
BM,
irrespective
their
primary
histology.
LUAD-BM
harbored
a
broad
repertoire
proto-oncogenes
with
tyrosine
kinase
activity
was
significantly
associated
APOBEC
enrichment
PTEN,
EGFR,
NF1
gene
mutations.
TP53
RB1
most
frequently
suppressor
SCLC-BM.
Gene
Ontology
analysis
indicated
that
SCLC-BM
LCLC-BM
deregulated
glial
proliferation
processes.
These
findings
provide
comprehensive
genomic
characterization
histologies.
Language: Английский
APOBEC3A, not APOBEC3B, drives deaminase mutagenesis in human gastric epithelium
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 31, 2024
Abstract
Cancer
genomes
frequently
carry
APOBEC
(apolipoprotein
B
mRNA
editing
catalytic
polypeptide-like)-associated
DNA
mutations,
suggesting
enzymes
as
innate
mutagens
during
cancer
initiation
and/or
evolution.
However,
the
pure
mutagenic
impacts
of
specific
among
this
family
that
are
responsible
for
APOBEC-associated
mutagenesis
remain
unclear,
particularly
comparative
activities
APOBEC3A
and
APOBEC3B
.
Here,
we
investigated
contributions
these
through
whole-genome
sequencing
human
normal
gastric
organoid
lines
carrying
doxycycline-inducible
or
cassettes.
Our
findings
demonstrated
transcriptional
upregulation
led
to
acquisition
a
massive
number
genomic
mutations
in
few
cell
cycles.
By
contrast,
did
not
generate
substantial
epithelium.
-associated
remained
insignificant
even
after
combined
inactivation
TP53
Based
on
spectrum
acquired
upregulation,
further
analyzed
mutational
signatures,
encompassing
indels
mainly
composed
1bp
deletions,
characteristics
clustered
selective
pressures
operative
cells
mutations.
observations
provide
clear
foundation
understanding
impact
cells.
Language: Английский
Guardian ubiquitin E3 ligases target cancer-associated APOBEC3 deaminases for degradation to promote human genome integrity
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 26, 2024
Abstract
Highlights
RNA-free
APOBEC3
(A3)
can
enter
the
nucleus,
leading
to
genomic
mutations.
Three
E3
ligases
specifically
bind
RNA-binding
domain
of
nuclear
A3s.
Cancer-associated
A3B
and
A3H-I
are
thereby
targeted
for
proteasomal
degradation.
These
thus
act
as
genome
guardians
by
limiting
A3-mediated
mutagenesis.
APOBEC
family
members
play
crucial
roles
in
antiviral
restriction.
However,
certain
proteins
drive
harmful
hypermutation
humans,
contributing
cancer.
The
cancer-associated
A3
capable
transiting
from
cytosol
where
they
cause
Here,
we
uncover
a
specific
set
cellular
pathways
that
protect
DNA
major
proteins.
Through
genetic
proteomic
screening
identify
UBR4,
UBR5,
HUWE1
key
ubiquitin
marking
degradation,
A3-driven
hypermutation.
Mechanistically,
UBR5
recognize
unoccupied
domains,
promoting
degradation
protein
is
not
engaged
its
function.
Depletion
or
mutation
cells
human
cancer
samples
increases
Our
findings
reveal
factors
ubiquitination
cascade
maintains
stability.
Language: Английский